Trials of a new gel that was supposed to reduce HIV infection rates were stopped when it appeared that the group recieving the gel actually had a
higher rate of infection than the controll group. It is unclear why this was the case. Three other drougs of a similar nature are undergoing trials in
Africa and results are expected by 2009.
This content community relies on user-generated content from our member contributors. The opinions of our members are not those of site ownership who maintains strict editorial agnosticism and simply provides a collaborative venue for free expression.